Turning cold into hot in the TME

This novel t-cell therapy offers oncologists the ability—for the first time ever—to effectively transform a low mutation burden (“cold”) tumor into a tumor with a high (or “hot”) mutation burden—thereby making it easier to effectively treat. The KIMMTRAK launch campaign brought that idea to life with a patient emerging from an ice cave into a sunlit landscape, holding the promise of improved outcomes and potentially a new era of treatment.